Timeline
Moderna
US mRNA vaccine company; running first-ever Phase 3 H5N1 mRNA trial as of April 2026.
1 of 1 entries (1 events, 0 interactions)
Filters
#122 Apr
US mRNA vaccine company; running first-ever Phase 3 H5N1 mRNA trial as of April 2026.
1 of 1 entries (1 events, 0 interactions)